Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer

NCT03825289 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Lack of Funding

Conditions

Metastatic Pancreatic Carcinoma
Stage II Pancreatic Cancer
Stage IIA Pancreatic Cancer
Stage IIB Pancreatic Cancer
Stage III Pancreatic Cancer
Stage IV Pancreatic Cancer
Unresectable Pancreatic Carcinoma

Interventions

DRUG: Hydroxychloroquine
DRUG: Trametinib

Sponsor

University of Utah

Collaborators

[object Object]
[object Object]